Brief: Theravance Announces Publication of YUPELRI® (revefenacin) Area
Oct 18 (Reuters) - Theravance Biopharma Inc TBPH.O :
* THERAVANCE ANNOUNCES PUBLICATION OF YUPELRI® (REVEFENACIN)
AREA
UNDER THE CURVE SPIROMETRY ANALYSIS IN THE INTERNATIONAL JOURNAL
OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source text for Eikon: ID:nPn33vMdLa
Further company coverage: TBPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions